These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25232763)

  • 1. Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus.
    Choudhary N; Chen L; Kotyra L; Wittlin SD; Alexis JD
    ASAIO J; 2014; 60(6):675-80. PubMed ID: 25232763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
    Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
    Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices.
    Guglin M; Maguire K; Missimer T; Faber C; Caldeira C
    ASAIO J; 2014; 60(3):290-3. PubMed ID: 24614357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact.
    Subauste AR; Esfandiari NH; Qu Y; Oral EA; Aaronson KD; Pagani FD; Gianchandani RG
    Hosp Pract (1995); 2014 Aug; 42(3):116-22. PubMed ID: 25255413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.
    Uriel N; Naka Y; Colombo PC; Farr M; Pak SW; Cotarlan V; Albu JB; Gallagher D; Mancini D; Ginsberg HN; Jorde UP
    Eur J Heart Fail; 2011 Feb; 13(2):195-9. PubMed ID: 21098576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
    Mohamedali B; Yost G; Bhat G
    Eur J Heart Fail; 2014 Oct; 16(10):1120-4. PubMed ID: 25298334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.
    Kyriakopoulos CP; Taleb I; Tseliou E; Sideris K; Hamouche R; Maneta E; Nelson M; Krauspe E; Selko S; Visker JR; Dranow E; Goodwin ML; Alharethi R; Wever-Pinzon O; Fang JC; Stehlik J; Selzman CH; Hanff TC; Drakos SG
    J Am Heart Assoc; 2024 Jul; 13(14):e032936. PubMed ID: 38989825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus.
    Goetz ME; Charnigo R; Guglin M
    Heart Lung Circ; 2020 Jun; 29(6):931-935. PubMed ID: 31235366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.
    Patel N; Gluck JA; Radojevic J; Coleman CI; Baker WL
    ESC Heart Fail; 2018 Dec; 5(6):1141-1149. PubMed ID: 30052326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.
    Usoh CO; Sherazi S; Szepietowska B; Kutyifa V; McNitt S; Papernov A; Wang M; Alexis JD
    Ann Thorac Surg; 2018 Aug; 106(2):555-560. PubMed ID: 29577927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen size improvement in advanced heart failure patients using a left ventricular assist device.
    Hiraiwa H; Okumura T; Sawamura A; Kondo T; Kazama S; Kimura Y; Shibata N; Arao Y; Oishi H; Kato H; Kuwayama T; Yamaguchi S; Furusawa K; Morimoto R; Murohara T
    Artif Organs; 2020 Jul; 44(7):700-708. PubMed ID: 32017166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes.
    Nguyen AB; Imamura T; Besser S; Rodgers D; Chung B; Raikhelkar J; Kalantari S; Smith B; Sarswat N; LaBuhn C; Jeevanandam V; Kim G; Sayer G; Uriel N
    J Am Heart Assoc; 2019 Nov; 8(22):e013278. PubMed ID: 31718441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.